IL127516A0 - A cytokine production inhibitor - Google Patents

A cytokine production inhibitor

Info

Publication number
IL127516A0
IL127516A0 IL12751697A IL12751697A IL127516A0 IL 127516 A0 IL127516 A0 IL 127516A0 IL 12751697 A IL12751697 A IL 12751697A IL 12751697 A IL12751697 A IL 12751697A IL 127516 A0 IL127516 A0 IL 127516A0
Authority
IL
Israel
Prior art keywords
cytokine production
production inhibitor
inhibitor
cytokine
production
Prior art date
Application number
IL12751697A
Other languages
English (en)
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of IL127516A0 publication Critical patent/IL127516A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/04Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12751697A 1996-06-12 1997-06-11 A cytokine production inhibitor IL127516A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP17426896 1996-06-12
JP9523797 1997-03-28
PCT/JP1997/002016 WO1997047622A1 (fr) 1996-06-12 1997-06-11 Inhibiteurs de production de cytokines, composes triazepine et intermediaires correspondants

Publications (1)

Publication Number Publication Date
IL127516A0 true IL127516A0 (en) 1999-10-28

Family

ID=26436510

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12751697A IL127516A0 (en) 1996-06-12 1997-06-11 A cytokine production inhibitor

Country Status (9)

Country Link
EP (1) EP0934940A1 (fr)
CN (1) CN1227555A (fr)
AU (1) AU3106197A (fr)
BR (1) BR9710453A (fr)
CA (1) CA2258053A1 (fr)
IL (1) IL127516A0 (fr)
NO (1) NO985820L (fr)
PL (1) PL330635A1 (fr)
WO (1) WO1997047622A1 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375465A4 (fr) 2001-04-03 2006-01-11 Eisai Co Ltd Derive de cyclooctanone et derive de cyclodecanone et utilisation de ces derives
JPWO2005089800A1 (ja) * 2004-03-17 2008-01-31 株式会社ロコモジェン hsHRD3を含む医薬組成物
EP2496945B1 (fr) * 2009-11-05 2015-04-01 GlaxoSmithKline LLC Nouveau procédé
AU2015203454B2 (en) * 2009-11-05 2017-02-23 Glaxosmithkline Llc Benzodiazepine bromodomain inhibitor
SI2496580T1 (sl) * 2009-11-05 2014-02-28 Glaxosmithkline Llc Benzodiazepinski inhibitorji bromodomene
KR20120097508A (ko) * 2009-11-05 2012-09-04 글락소스미스클라인 엘엘씨 벤조디아제핀 브로모도메인 억제제
GB0919426D0 (en) * 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
CN103154246B (zh) 2010-05-14 2015-11-25 达那-法伯癌症研究所 用于治疗白血病的组合物和方法
PT2571503E (pt) * 2010-05-14 2015-04-29 Dana Farber Cancer Inst Inc Composições e a sua utilização no tratamento de neoplasia, doença inflamatória e outros distúrbios
JP6022442B2 (ja) 2010-05-14 2016-11-09 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド 男性用避妊組成物および使用方法
JP5715241B2 (ja) * 2010-05-14 2015-05-07 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
JP5844358B2 (ja) 2010-06-22 2016-01-13 グラクソスミスクライン エルエルシー ベンゾトリアゾロジアゼピン化合物を含むブロモドメイン阻害剤
TWI583689B (zh) * 2010-08-04 2017-05-21 達納 法柏癌症學院有限公司 治療腫瘤形成、發炎疾病及其他病症之組成物及方法
AR084070A1 (es) * 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012075456A1 (fr) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Inhibiteurs de bromodomaines et leurs utilisations
US9422292B2 (en) 2011-05-04 2016-08-23 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
DE102011082013A1 (de) 2011-09-01 2013-03-07 Bayer Pharma AG 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
CN102603743B (zh) * 2012-02-24 2014-05-28 南京天易生物科技有限公司 抗肿瘤的氮杂苯并[f]薁衍生物其制备方法及其用途
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
MX2015001880A (es) 2012-08-16 2015-05-11 Bayer Pharma AG 2,3-benzodiacepinas.
CN104781259B (zh) 2012-09-28 2018-06-01 拜耳制药股份公司 抑制bet蛋白的5-芳基三唑并氮杂*
RU2016105108A (ru) 2013-07-25 2017-08-30 Дана-Фарбер Кэнсер Инститьют, Инк. Ингибиторы факторов транскрипции и их применение
WO2015070020A2 (fr) 2013-11-08 2015-05-14 Dana-Farber Cancer Institute, Inc. Polythérapie pour le traitement du cancer utilisant des inhibiteurs de protéine à bromodomaine et à domaine extra-terminal (bet)
JP2017504651A (ja) 2014-01-31 2017-02-09 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド ジアゼパン誘導体の使用
KR20160115953A (ko) 2014-01-31 2016-10-06 다나-파버 캔서 인스티튜트 인크. 디아미노피리미딘 벤젠술폰 유도체 및 그의 용도
MX2016011160A (es) 2014-02-28 2017-04-27 Tensha Therapeutics Inc Tratamiento de afecciones asociadas con la hiperinsulinemia.
CN106687463B (zh) 2014-06-20 2019-04-09 星座制药公司 一种乙酰胺类化合物的晶型
BR112017002369A2 (pt) 2014-08-08 2017-12-05 Dana Farber Cancer Inst Inc derivados de diazepana e usos dos mesmos
JP2017525759A (ja) 2014-08-08 2017-09-07 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド ジヒドロプテリジノン誘導体およびその使用
CN106715439A (zh) * 2014-10-02 2017-05-24 葛兰素史克知识产权第二有限公司 化合物
EP3212654B1 (fr) 2014-10-27 2020-04-08 Tensha Therapeutics, Inc. Inhibiteurs de bromodomaine
EP3307728A4 (fr) 2015-06-12 2019-07-17 Dana Farber Cancer Institute, Inc. Thérapie d'association utilisant des inhibiteurs de transcription et des inhibiteurs de kinases
SG10202007099TA (en) 2015-09-11 2020-08-28 Dana Farber Cancer Inst Inc Acetamide thienotriazoldiazepines and uses thereof
JP2018526421A (ja) 2015-09-11 2018-09-13 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド シアノチエノトリアゾロジアゼピンおよびこれらの使用
EP3380100A4 (fr) 2015-11-25 2019-10-02 Dana-Farber Cancer Institute, Inc. Inhibiteurs de bromodomaines bivalents et leurs utilisations
AU2017339942B2 (en) * 2016-10-03 2023-06-29 Dompe Farmaceutici S.P.A. Prevention and treatment of diabetic nephropathy
KR102592845B1 (ko) * 2017-05-31 2023-10-20 아유미 세이야쿠 가부시키가이샤 6H-티에노[2,3-e][1,2,4]트리아졸로[3,4-c][1,2,4]트리아제핀 유도체
WO2019238557A1 (fr) * 2018-06-13 2019-12-19 Dybly Ag Préparation de dérivés condensés de triazépine et leur utilisation comme inhibiteurs de bet

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489980A (en) * 1975-01-20 1977-10-26 Upjohn Co Reaction products of 3-amino-3,4-dihydro-4-hydroxy-4-phenylquinazolines
US4144233A (en) * 1977-02-16 1979-03-13 The Dow Chemical Company Method for preparing benzo-(1,3,4)-benzotriazepines
JP2622673B2 (ja) * 1994-11-18 1997-06-18 日本たばこ産業株式会社 骨粗鬆症治療薬およびトリアゼピン化合物
CA2205173A1 (fr) * 1994-11-18 1996-05-30 Takeshi Nakamura Remede contre l'osteoporose et compose de triazepine

Also Published As

Publication number Publication date
NO985820D0 (no) 1998-12-11
WO1997047622A1 (fr) 1997-12-18
CN1227555A (zh) 1999-09-01
CA2258053A1 (fr) 1997-12-18
AU3106197A (en) 1998-01-07
NO985820L (no) 1999-02-01
EP0934940A1 (fr) 1999-08-11
BR9710453A (pt) 1999-08-17
PL330635A1 (en) 1999-05-24

Similar Documents

Publication Publication Date Title
IL127516A0 (en) A cytokine production inhibitor
HRP970601B1 (en) A cubical
EP0771564A4 (fr) Inhibiteur de production de l'interleukine-5
AU3192695A (en) Interleukin-5 production inhibitor
GB9600517D0 (en) A bio-enhancer
GB2333294B (en) Cytokine production inhibitors
GB9612078D0 (en) Building a production line
ZA9811349B (en) Statin-lp (a) inhibitor combinations
GB9604010D0 (en) A technical drawing aid
IL112244A0 (en) Novel inhibitor
AU134857S (en) A table
GB2320666B (en) A structure
GB9601433D0 (en) A lunch-box
GB2313539B (en) A table
GB9618464D0 (en) A bangle
CA79623S (en) A pendant
AU125847S (en) A tile
AU130811S (en) A bidette
GB9725127D0 (en) A triblet
AU127690S (en) A keyrack
KR970063980U (ko) 컴팩트 디스크 드라이브용 나사축의 축받침구조
AU128546S (en) A table
AU128087S (en) A table
AU126851S (en) A brick
GB9617911D0 (en) A structural section